中国医药生物技术
中國醫藥生物技術
중국의약생물기술
CHINESE MEDICINAL BIOTECHNOLOGY
2014年
2期
124-128
,共5页
鞠瑞%陈晨%郭磊%李娟%叶菜英%张德昌
鞠瑞%陳晨%郭磊%李娟%葉菜英%張德昌
국서%진신%곽뢰%리연%협채영%장덕창
肿瘤坏死因子 α%巨噬细胞%共培养%羧胺三唑
腫瘤壞死因子 α%巨噬細胞%共培養%羧胺三唑
종류배사인자 α%거서세포%공배양%최알삼서
Tumor necrosis factor-alpha%Macrophages%Co-culture%Carboxyamidotriazole
目的观察体外培养的肿瘤细胞对巨噬细胞炎症因子--肿瘤坏死因子-α(TNF-α)的诱导作用;初步探索羧胺三唑(CAI)对肿瘤诱导的巨噬细胞中 TNF-α释放的影响。方法利用 transwell 装置,建立 Lewis 肺癌细胞(LLC)与 RAW264.7巨噬细胞共培养体系,采用荧光定量 PCR方法和 ELISA 方法分别分析 RAW264.7中 TNF-α的表达和释放;用 LLC 条件培养基(LCM)诱导 RAW264.7,同时给予 CAI 处理,采用 CCK-8方法分析 LCM 和 CAI对 RAW264.7活力的影响,采用 ELISA 方法分析 CAI 对诱导后的 RAW264.7中 TNF-α释放的影响。<br> 结果与 LLC 共培养24 h 可显著增加 RAW264.7中TNF-α相对表达量[单独培养 vs 共培养,(1.00±0.12)vs (2.23±0.17),P <0.01]和释放[单独培养 vs 共培养,(65.21±12.76)vs (143.92±19.22)pg/ml,P<0.05];LCM 和 CAI 在1 h 和4 h 对 RAW264.7活力没有影响,CAI 可以显著抑制 LCM 对 RAW264.7中 TNF-α释放的诱导(4 h,P<0.01)。<br> 结论 LLC 肿瘤微环境可以诱导 RAW264.7中 TNF-α的表达增加;CAI 对这种诱导的抑制使其在肿瘤环境中表现出一定的抗炎作用,可能是其抗肿瘤作用的机制之一。
目的觀察體外培養的腫瘤細胞對巨噬細胞炎癥因子--腫瘤壞死因子-α(TNF-α)的誘導作用;初步探索羧胺三唑(CAI)對腫瘤誘導的巨噬細胞中 TNF-α釋放的影響。方法利用 transwell 裝置,建立 Lewis 肺癌細胞(LLC)與 RAW264.7巨噬細胞共培養體繫,採用熒光定量 PCR方法和 ELISA 方法分彆分析 RAW264.7中 TNF-α的錶達和釋放;用 LLC 條件培養基(LCM)誘導 RAW264.7,同時給予 CAI 處理,採用 CCK-8方法分析 LCM 和 CAI對 RAW264.7活力的影響,採用 ELISA 方法分析 CAI 對誘導後的 RAW264.7中 TNF-α釋放的影響。<br> 結果與 LLC 共培養24 h 可顯著增加 RAW264.7中TNF-α相對錶達量[單獨培養 vs 共培養,(1.00±0.12)vs (2.23±0.17),P <0.01]和釋放[單獨培養 vs 共培養,(65.21±12.76)vs (143.92±19.22)pg/ml,P<0.05];LCM 和 CAI 在1 h 和4 h 對 RAW264.7活力沒有影響,CAI 可以顯著抑製 LCM 對 RAW264.7中 TNF-α釋放的誘導(4 h,P<0.01)。<br> 結論 LLC 腫瘤微環境可以誘導 RAW264.7中 TNF-α的錶達增加;CAI 對這種誘導的抑製使其在腫瘤環境中錶現齣一定的抗炎作用,可能是其抗腫瘤作用的機製之一。
목적관찰체외배양적종류세포대거서세포염증인자--종류배사인자-α(TNF-α)적유도작용;초보탐색최알삼서(CAI)대종류유도적거서세포중 TNF-α석방적영향。방법이용 transwell 장치,건립 Lewis 폐암세포(LLC)여 RAW264.7거서세포공배양체계,채용형광정량 PCR방법화 ELISA 방법분별분석 RAW264.7중 TNF-α적표체화석방;용 LLC 조건배양기(LCM)유도 RAW264.7,동시급여 CAI 처리,채용 CCK-8방법분석 LCM 화 CAI대 RAW264.7활력적영향,채용 ELISA 방법분석 CAI 대유도후적 RAW264.7중 TNF-α석방적영향。<br> 결과여 LLC 공배양24 h 가현저증가 RAW264.7중TNF-α상대표체량[단독배양 vs 공배양,(1.00±0.12)vs (2.23±0.17),P <0.01]화석방[단독배양 vs 공배양,(65.21±12.76)vs (143.92±19.22)pg/ml,P<0.05];LCM 화 CAI 재1 h 화4 h 대 RAW264.7활력몰유영향,CAI 가이현저억제 LCM 대 RAW264.7중 TNF-α석방적유도(4 h,P<0.01)。<br> 결론 LLC 종류미배경가이유도 RAW264.7중 TNF-α적표체증가;CAI 대저충유도적억제사기재종류배경중표현출일정적항염작용,가능시기항종류작용적궤제지일。
Objective To investigate the tumor necrosis factor-α(TNF-α) expression and secretion enhancement in macrophages induced by tumor cells in vitro, as well as the inhibitory effect of carboxyamidotriazole (CAI) on TNF-α induction in tumor-educated macrophages. <br> Methods The Lewis lung carcinoma (LLC) cells and RAW264.7 macrophages were co-cultured with the transwell inserts, LLC conditioned medium (LCM) was also used to induce RAW264.7 with or without CAI treatment. Real time RT-PCR and ELISA methods were applied to analyze the TNF-αexpression and secretion in RAW264.7, respectively. CCK-8 was applied to determine the effect of LLC (LCM) and CAI on the viability of RAW264.7. <br> Results TNF-αexpression [cultured alone vs co-cultured, (1.00 ± 0.12) vs (2.23 ± 0.17), P<0.01] and secretion [cultured alone vs co-cultured, (65.21 ± 12.76) vs (143.92 ± 19.22) pg/ml, P<0.05] were greatly increased in RAW264.7 after being co-cultured with LLC for 24 hours. LCM and CAI did not influence the viability of RAW264.7 at 1 hour and 4 hour, while CAI inhibited TNF-αsecretion in RAW264.7 induced by LCM (4 h, P<0.01). <br> Conclusion LLC tumor environment can greatly enhance the TNF-α expression in RAW264.7. CAI inhibits this induction significantly and shows anti-inflammation activity in tumor environment, which may contribute to its anti-cancer effects.